Tumor microenvironment distinctions between esophageal cancer subtypes explain varied immunotherapy responses

Seungbyn Baek,Junha Cha,Min-Hee Hong,Gamin Kim,Yoon Woo Koh,Dahee Kim,Martin Hemberg,Seong Yong Park,Hye Ryun Kim,Insuk Lee
DOI: https://doi.org/10.1101/2024.09.24.614705
2024-09-26
Abstract:Esophageal cancer comprises two main subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). Previous studies have revealed distinct genomic characteristics between these subtypes, with ESCC sharing similarities with head and neck squamous cell carcinoma (HNSCC), and EAC aligning with gastric adenocarcinoma (GAC). Additionally, recent immunotherapy clinical trials have shown a higher response rate in ESCC and HNSCC compared to EAC and GAC. However, how the tumor microenvironment contributes to these varied immunotherapy responses remains unclear. In this study, through a comparative analysis of single-cell tumor transcriptomes from 35 patients with ESCC, EAC, HNSCC, or GAC, we identified two groups with tumor microenvironment distinctions: ESCC and HNSCC versus EAC and GAC, consistent with their genomic classifications. Malignant epithelial cells displayed distinct separations based on histological origin. In the tumor immune microenvironment, we observed an enrichment of CXCL13+CD8+ T cells and CXCL9+CXCL10+ tumor-associated macrophages (TAMs) in ESCC and HNSCC, which activate cellular immunity through interferon-γ. In contrast, EAC and GAC exhibited a high presence of heat-shock protein-expressing CD8+ T cells and MARCO+ TAMs. These immune signatures help explain the varied immunotherapy responses among these cancer subtypes and successfully predict immunotherapy outcomes across diverse cancer types, underscoring their clinical significance.
Cancer Biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: How can the differences in the tumor microenvironment (TME) between different esophageal cancer subtypes (esophageal squamous cell carcinoma ESCC and esophageal adenocarcinoma EAC) explain their different responses to immunotherapy? Specifically, by comparative analysis of single - cell tumor transcriptomes of 35 patients with ESCC, EAC, head and neck squamous cell carcinoma (HNSCC) or gastric adenocarcinoma (GAC), the researchers identified two groups with different tumor microenvironment characteristics: ESCC and HNSCC, and EAC and GAC. These differences are mainly reflected in the separation of malignant epithelial cells based on histological origin and the changes in specific immune cell types observed in the tumor - immune microenvironment. For example, CXCL13+CD8+ T cells and CXCL9+CXCL10+ tumor - associated macrophages (TAMs) are enriched in ESCC and HNSCC, and these cells activate cellular immunity through interferon - γ; while in EAC and GAC, CD8+ T cells with high expression of heat shock proteins and MARCO+ TAMs are observed. These immune characteristics help to explain the differences in the responses of different cancer subtypes to immunotherapy and can predict the immunotherapy outcomes across multiple cancer types, highlighting their clinical significance.